Pediatr. praxi. 2023;24(6):398-402 | DOI: 10.36290/ped.2023.096

Diagnostic significance of postnatal interleukin-6 dynamics in preterm neonates

MUDr. Anna Baštan1, MUDr. Jan Hálek, Ph.D.1, 2, RNDr. Tomáš Fürst, Ph.D.3, prof. MUDr. Vladimír Mihál, CSc.1
1 Dětská klinika, Fakultní nemocnice a Lékařské fakulty Univerzity Palackého Olomouc
2 Novorozenecké oddělení, Fakultní nemocnice Olomouc
3 Katedra matematické analýzy a aplikací matematiky, Přírodovědecká fakulta Univerzita Palackého, Olomouc

Introduction: The aim of this study was to compare interleukin-6 values in umbilical cord and peripheral blood of newborns. The clinical goal was to determine whether the examination of cord blood can replace early postnatal peripheral blood collection.

Patients and methods: Study included premature newborns (< 35th week of gestation) born in 2016-2018 at Olomouc University Hospital. At the same time, it was possible to collect a sufficient amount of blood from the umbilical cord in these newborns.

Results: Paired sampling was successful in 73 of these newborns. A significant difference (p < 0,001) was found between the umbilical cord and peripheral interleukin-6 values. The median of the first measurement (cord blood) was 6,5 ng/l, the median of the second measurement (peripheral blood) was 56 ng/l. The increase is almost ten times bigger.

Conclusion: The difference of values between interleukin-6 from umbilical cord blood and from early postnatal collection are significantly different and it is necessary to keep it in mind during its clinical use.

Keywords: newborn, sepsis, interleukin-6, umbilical cord.

Accepted: November 14, 2023; Published: November 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Baštan A, Hálek J, Fürst T, Mihál V. Diagnostic significance of postnatal interleukin-6 dynamics in preterm neonates. Pediatr. praxi. 2023;24(6):398-402. doi: 10.36290/ped.2023.096.
Download citation

References

  1. Bizzarro MJ, Dembry LM, Baltimore RS, et al. Changing patterns in neonatal escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008;121(4):689-696. doi: 10.1542/peds. 2007-2171. Go to original source... Go to PubMed...
  2. Silverman MA, Konnikova L, Gerber JS. Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea. Gastroenterol Clin North Am. 2017;46(1):61-76. Go to original source... Go to PubMed...
  3. Modi N, Doré CJ, Saraswatula A, et al. A case definition for national and international neonatal bloodstream infection surveillance. Arch Dis Child - Fetal Neonatal Ed. 2009;94(1):F8-12. http://fn.bmj.com/content/94/1/F8.abstract. Go to original source... Go to PubMed...
  4. Klingenberg C, Kornelisse RF, Buonocore G, et al. Culture-negative early-onset neonatal sepsis - at the crossroad between efficient sepsis care and antimicrobial stewardship. Front Pediatr. 2018;6(285):1-9. doi: 10.3389/fped.2018.00285. Go to original source... Go to PubMed...
  5. Ng PC, Ma TPY, Lam HS. The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2015;0:1-5. doi: 10.1136/archdischild-2014-307656. Go to original source... Go to PubMed...
  6. Ulevitch RJ. Therapeutics targeting the innate immune system. Nat Rev Immunol. 2004;4(7):512-520. doi: 10.1038/nri1396. Go to original source... Go to PubMed...
  7. Medkova A, Srovnal J, Potomkova J, et al. Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology. World J Pediatr. 2018;14(4). doi: 10.1007/s12519-018-0163-5. Go to original source... Go to PubMed...
  8. Dias ML, O'Connor KM, Dempsey EM, et al. Targeting the Toll-like receptor pathway as a therapeutic strategy for neonatal infection. Am J Physiol Integr Comp Physiol. 2021;321(6):R879-R902. doi: 10.1152/ajpregu.00307.2020. Go to original source... Go to PubMed...
  9. Kollmann TR, Kampmann B, Mazmanian SK, et al. Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny. Immunity. 2017;46(3):350-363. doi: 10.1016/j.immuni.2017.03.009. Go to original source... Go to PubMed...
  10. Cava F, González C, Pascual M, et al. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 recenptor (sIL2R) in serum of healthy individuals. Cytokine. 2000;12(9):1423-1425. doi: 10.1006/CYTO.2000.0714. Go to original source... Go to PubMed...
  11. Li M, Pan S, Chen H, et al. Effect of TLR-4 gene polymorphism on sepsis susceptibility in neinatel: a systemic review and meta-analysis. Biomark Med. 2022;16(13):1005-1017. Go to original source... Go to PubMed...
  12. Krueger M, Nauck MS, Sang S, et al. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate. 2001;80(2):118-123. doi: 10.1159/000047130. Go to original source... Go to PubMed...
  13. Abdollahi A, Shoar S, Nayyeri F, et al. Diagnostic value of simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis. Mediterr J Hematol Infect Dis. 2012;4(1). doi: 10.4084/MJHID.2012.028. Go to original source... Go to PubMed...
  14. Chiesa C, Signore F, Assumma M, et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: Reference intervals and analysis of maternal and perinatal confounders. Clin Chem. 2001;47(6):1016-1022. doi: 10.1093/clinchem/47.6.1016. Go to original source...
  15. Tanaka T, Masashi Narazaki TK. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol. 2014;6. doi: 10.1101/cshperspect.a005728. Go to original source... Go to PubMed...
  16. Døllner H, Vatten L, Linnebo I, et al. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate. 2001;80(1):41-47. Go to original source... Go to PubMed...
  17. Velemínský MJ, Stránský P, Velemínský SS, et al. Relationship of IL-6, IL-8, TNF and sICAM-1 levels to PROM, pPROM, and the risk of early-onset neonatal sepsis. Neuro Endocrinol Lett. 2008;29(3):303-311.
  18. Weeks J, Reynolds L, Taylor D, et al. Umbilical cord blood interleukin-6 levels and neonatal morbidity. Obstet Gynecol. 1997;90(5):815-818. Go to original source... Go to PubMed...
  19. Cernada M, Badía N, Modesto V, et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr Int J Paediatr. 2011;101(5):203-207. doi: 10.1111/j.1651-2227.2011.02577.x. Go to original source... Go to PubMed...
  20. Cobo T, Kacerovsky M, Andrys C, et al. Umbilical Cord Blood IL-6 as Predictor of Early-Onset Neonatal Sepsis in Women with Preterm Prelabour Rupture of Membranes. PLoS One. 2013;8(7):4-9. doi: 10.1371/journal.pone.0069341. Go to original source... Go to PubMed...
  21. Fan Y, Yu JL. Umbilical blood biomarkers for predicting early-onset neonatal sepsis. World J Pediatr. 2012;8(2):101-108. doi: 10.1007/s12519-012-0347-3. Go to original source... Go to PubMed...
  22. Steinberger E, Hofer N, Resch B. Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants. Scand J Clin Lab Invest. 2014;74(5):432-436. doi: 10.3109/00365513.2014.900696. Go to original source... Go to PubMed...
  23. Santana C, Guindeo M, González G, et al. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr. 2001;90(10):1176-1181. doi: 10.1080/080352501317061602. Go to original source... Go to PubMed...
  24. Marhukumar R, Thangam EB. Differential regulation of inflammatory mediators and granule-associated mediators in neonatal sepsis observed in cord and peripheral blood. Int J Interf Cytokine Mediat Res. 2013;5:33-37. doi: https://doi.org/10.2147/IJICMR.S54301. Go to original source...
  25. Eichberger J, Resch B. Reliability of Interleukin-6 Alone and in Combination for Diagnosis of Early Onset Neonatal Sepsis: Systematic Review. Front Pediatr. 2022;10(March). doi: 10.3389/fped.2022.840778. eCollection 2022. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.